Krystle A Lang Kuhs

Title: Krystle A Lang Kuhs: Innovator in HCV Vaccine Development

Introduction

Krystle A Lang Kuhs is a prominent inventor based in Bethesda, MD (US). She has made significant contributions to the field of vaccine development, particularly in the area of hepatitis C virus (HCV) research. Her innovative work has the potential to impact public health positively.

Latest Patents

Krystle holds a patent for "HCV vaccines and methods for using the same." This patent includes improved anti-HCV immunogens and nucleic acid molecules that encode them. The immunogens disclosed in her patent feature consensus HCV genotype 1 a/1 b NS3 and NS4A. Additionally, her work encompasses pharmaceutical compositions, recombinant vaccines, and live attenuated vaccines. Methods for inducing an immune response in individuals against HCV are also detailed in her patent.

Career Highlights

Throughout her career, Krystle has worked with esteemed organizations such as the University of Pennsylvania and Inovio Pharmaceuticals, Inc. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of her notable coworkers include David B Weiner and Jian Yan. Their collaborative efforts have further advanced the research and development of HCV vaccines.

Conclusion

Krystle A Lang Kuhs is a trailblazer in the field of HCV vaccine development, with a patent that showcases her innovative approach to combating this virus. Her work continues to inspire advancements in medical research and public health initiatives.